Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Philip Morris
PM
$295B
| $871M | 0.21% |
4,814,013
+23,476
| +0.5% | +$4.03M |
|
102
KLA
KLAC
$253B
| $856M | 0.21% |
9,610,210
-477,530
| -5% | -$35.9M |
|
103
RTX Corp
RTX
$299B
| $854M | 0.21% |
5,850,960
+233,533
| +4% | +$31.1M |
|
104
S&P Global
SPGI
$121B
| $839M | 0.21% |
1,596,875
+118,034
| +8% | +$58.9M |
|
105
Boston Scientific
BSX
$68.4B
| $838M | 0.21% |
7,786,959
-64,744
| -0.8% | -$6.55M |
|
|
SCHW
106
Charles Schwab
SCHW
$188B
| $836M | 0.21% |
9,162,235
-600,147
| -6% | -$50.3M |
|
107
Adobe
ADBE
$102B
| $832M | 0.21% |
2,151,063
-663,362
| -24% | -$256M |
|
108
Valero Energy
VLO
$87.5B
| $824M | 0.2% |
6,131,787
-1,408,584
| -19% | -$176M |
|
109
Northrop Grumman
NOC
$78.8B
| $810M | 0.2% |
1,619,814
-22,356
| -1% | -$11M |
|
110
Marvell Technology
MRVL
$192B
| $805M | 0.2% |
10,406,875
+1,464,571
| +16% | +$91.4M |
|
111
NXP Semiconductors
NXPI
$58.3B
| $779M | 0.19% |
3,567,140
+162,553
| +5% | +$31.8M |
|
112
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.32B
| $754M | 0.19% |
17,219,195
+1,188,147
| +7% | +$51.5M |
|
113
Texas Instruments
TXN
$254B
| $754M | 0.19% |
3,683,459
-712,553
| -16% | -$126M |
|
|
114
Gilead Sciences
GILD
$164B
| $748M | 0.18% |
6,748,403
+5,392,191
| +398% | +$574M |
|
115
NetApp
NTAP
$37.1B
| $735M | 0.18% |
6,896,613
-200,066
| -3% | -$19M |
|
116
Elevance Health
ELV
$84.9B
| $730M | 0.18% |
1,875,977
-67,639
| -3% | -$27.2M |
|
117
Corning
GLW
$136B
| $724M | 0.18% |
13,763,148
+1,036,988
| +8% | +$48.5M |
|
118
Take-Two Interactive
TTWO
$44.1B
| $721M | 0.18% |
2,966,504
-872,329
| -23% | -$197M |
|
119
Prologis
PLD
$131B
| $712M | 0.18% |
6,805,570
-1,235,172
| -15% | -$130M |
|
120
Vanguard FTSE Developed Markets ETF
VEA
$235B
| $711M | 0.18% |
12,466,019
+279,856
| +2% | +$15M |
|
121
Mercado Libre
MELI
$97.2B
| $710M | 0.17% |
271,202
+9,474
| +4% | +$22.1M |
|
122
CrowdStrike
CRWD
$217B
| $696M | 0.17% |
5,465,276
-541,068
| -9% | -$58.6M |
|
123
Amgen
AMGN
$218B
| $689M | 0.17% |
2,467,959
+345,242
| +16% | +$97.8M |
|
124
Vanguard Morningstar Total Stock Market ETF
VTI
$682B
| $688M | 0.17% |
2,261,816
-180,070
| -7% | -$50.6M |
|
125
Thermo Fisher Scientific
TMO
$213B
| $685M | 0.17% |
1,688,885
-387,749
| -19% | -$162M |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.